There are 333 papers on RUNX2 in aging research: 2 trials and 25 observational studies in people, 219 in animals, 65 in cells, 20 reviews. The newest story, Oct 31, 2026: “Loss of a regulatory protein worsened bone loss in mice”.
RUNX2 increases dental-follicle senescence in a heterozygous-knockout mouse study, while one group links it with lower senescence in dental follicles from people with cleidocranial dysplasia and RUNX2 mutations. A mouse study reports increased osteoarthritis risk with RUNX2 after chondrocyte kindlin-2 deletion. The National Natural Science Foundation of China is a frequently named funder.
44 findings in 38 papers from 2009 to 2026, 11 of them since April 2026
The findings reach people, from one lab or study. 35 independent labs in 15 countries.
“a significant reduction in SA-β-gal-positive and P16 INK4a -positive cells in CCD patients compared with healthy controls”
Cells, mice and humans: a single group. Worms or flies: nothing yet.
C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.
Labs are independent when their papers share no last author and no institution.
Against: findings that point the other way from most findings on the same outcome.
Includes the processes named after it and trials of drugs aimed at it.
35 independent labs in 15 countries
1 finding against
Funders: National Natural Science Foundation of China and others
Human trial2
Humans25
Animals219
Cells65
In silico2
Interventions
23
Sciadopitysin
↑upin rats1
1 study
Sciadopitysin increases RUNX2 in ovariectomized rats.
RUNX2 is associated with lumbar spine bone mineral density in humans (postmenopausal women; RUNX2 T > C, CC versus TC + TT under a recessive model) (SDM = -0.451; p = 0.032).
Reviewpostmenopausal women; RUNX2 T > C, CC versus TC + TT under a recessive modellumbar spinefemales
Experiments found that mice lacking SIRT5, a protein that modifies other proteins, had poorer bone formation and more severe bone loss than normal mice.Experiments found that mice lacking SIRT5, a protein that modifies other proteins, had poorer bone formation and more severe bone loss than normal mice.
Virus-based supplementation of a stem-cell regulator eased obesity, osteoporosis or both across three mouse models.Virus-based supplementation of a stem-cell regulator eased obesity, osteoporosis or both across three mouse models.